These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21042826)

  • 1. A surveillance of high-level gentamicin-resistant enterococcal bacteremia.
    Araoka H; Kimura M; Yoneyama A
    J Infect Chemother; 2011 Jun; 17(3):433-4. PubMed ID: 21042826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A surveillance of high-level gentamicin-resistant enterococcal bacteremia.
    Araoka H; Kimura M; Yoneyama A
    Kansenshogaku Zasshi; 2012 Mar; 86(2 Suppl 4):27-8. PubMed ID: 23115941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features, risk factors and outcomes of bacteremia due to enterococci with high-level gentamicin resistance: comparison with bacteremia due to enterococci without high-level gentamicin resistance.
    Jang HC; Lee S; Song KH; Jeon JH; Park WB; Park SW; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
    J Korean Med Sci; 2010 Jan; 25(1):3-8. PubMed ID: 20052340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin.
    Watanakunakorn C; Patel R
    Clin Infect Dis; 1993 Jul; 17(1):74-8. PubMed ID: 8353250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, epidemiological, and microbiological characteristics of bacteremia caused by high-level gentamicin-resistant Enterococcus faecalis.
    Vigani AG; Oliveira AM; Bratfich OJ; Stucchi RS; Moretti ML
    Braz J Med Biol Res; 2008 Oct; 41(10):890-5. PubMed ID: 19030711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterococcal bacteraemia: epidemiological, microbiological, clinical and prognostic characteristics, and the impact of high level gentamicin resistance.
    Shaked H; Carmeli Y; Schwartz D; Siegman-Igra Y
    Scand J Infect Dis; 2006; 38(11-12):995-1000. PubMed ID: 17148067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular epidemiology of Enterococcus faecalis bacteremia, with special reference to strains with high-level resistance to gentamicin.
    Antalek MD; Mylotte JM; Lesse AJ; Sellick JA
    Clin Infect Dis; 1995 Jan; 20(1):103-9. PubMed ID: 7727634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method.
    Tascini C; Doria R; Leonildi A; Martinelli C; Menichetti F
    J Chemother; 2004 Aug; 16(4):400-3. PubMed ID: 15332717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of enterococcal bacteremia due to ampicillin-susceptible and ampicillin-resistant enterococci: An eight-year retrospective comparison study.
    Hamada Y; Magarifuchi H; Oho M; Kusaba K; Nagasawa Z; Fukuoka M; Yamakuchi H; Urakami T; Aoki Y
    J Infect Chemother; 2015 Jul; 21(7):527-30. PubMed ID: 25935477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment with ampicillin and fluoroquinolones of human endocarditis due to high-level gentamicin-resistant enterococci.
    Tripodi MF; Locatelli A; Adinolfi LE; Andreana A; Utili R
    Eur J Clin Microbiol Infect Dis; 1998 Oct; 17(10):734-6. PubMed ID: 9865990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enterococcal endocarditis revisited.
    Pericás JM; Zboromyrska Y; Cervera C; Castañeda X; Almela M; Garcia-de-la-Maria C; Mestres C; Falces C; Quintana E; Ninot S; Llopis J; Marco F; Moreno A; Miró JM
    Future Microbiol; 2015; 10(7):1215-40. PubMed ID: 26118390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM
    Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
    Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E
    Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enterococcal endocarditis: a multicenter study of 76 cases].
    Martínez-Marcos FJ; Lomas-Cabezas JM; Hidalgo-Tenorio C; de la Torre-Lima J; Plata-Ciézar A; Reguera-Iglesias JM; Ruiz-Morales J; Márquez-Solero M; Gálvez-Acebal J; de Alarcón-González A;
    Enferm Infecc Microbiol Clin; 2009 Dec; 27(10):571-9. PubMed ID: 19477041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.
    Pericas JM; Cervera C; del Rio A; Moreno A; Garcia de la Maria C; Almela M; Falces C; Ninot S; Castañeda X; Armero Y; Soy D; Gatell JM; Marco F; Mestres CA; Miro JM;
    Clin Microbiol Infect; 2014 Dec; 20(12):O1075-83. PubMed ID: 25040215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study.
    Chirouze C; Athan E; Alla F; Chu VH; Ralph Corey G; Selton-Suty C; Erpelding ML; Miro JM; Olaison L; Hoen B;
    Clin Microbiol Infect; 2013 Dec; 19(12):1140-7. PubMed ID: 23517406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility patterns and high-level gentamicin resistance among enterococci isolated in a Mexican tertiary care center.
    Sifuentes-Osornio J; Ponce-de-León A; Muñoz-Trejo T; Villalobos-Zapata Y; Ontiveros-Rodríguez C; Gómez-Roldán C
    Rev Invest Clin; 1996; 48(2):91-6. PubMed ID: 8815502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 10-year profile of enterococcal bloodstream infections at a tertiary-care hospital in Japan.
    Suzuki H; Hase R; Otsuka Y; Hosokawa N
    J Infect Chemother; 2017 Jun; 23(6):390-393. PubMed ID: 28385565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management.
    Maki DG; Agger WA
    Medicine (Baltimore); 1988 Jul; 67(4):248-69. PubMed ID: 3134590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.